bf/NASDAQ:AURA_icon.jpeg

NASDAQ:AURA

Aura Biosciences, Inc.

  • Stock

6.07

+4.12%

−0.62

USD last updated 19/08 02:06:19

Last Close

6.69

18/08 20:00

Market Cap

367.12M

Beta: -

Volume Today

157.64K

Avg: 116.01K

PE Ratio

−3.16

PFCF: −5.86

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular onc...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -25-20-15-10-52020-03-302020-12-312021-09-302022-12-302024-05-062024-11-14

    Revenue (Estimate*)

    0.000.000.010.010.012020-03-302020-12-312021-09-302022-12-302024-05-062024-11-14

    *Estimate based on analyst consensus